Multicentre, randomised, double-blind, parallel controlled trial to investigate timing of platelet inhibition after coronary artery bypass grafting: TOP-CABG trial study

INTRODUCTION: Dual antiplatelet therapy (DAPT), referred to as the combination of aspirin and P2Y(12) receptor antagonist (clopidogrel or ticagrelor), potentially improves patency of saphenous vein grafts (SVG) after coronary artery bypass grafting (CABG), while it is further proposed that DAPT pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Xin, Chu, Qing, Chen, Kai, Wang, Yang, Zhang, Lihua, Zheng, Yingli, Hu, Shengshou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314523/
https://www.ncbi.nlm.nih.gov/pubmed/37385747
http://dx.doi.org/10.1136/bmjopen-2022-070823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314523/
https://www.ncbi.nlm.nih.gov/pubmed/37385747
http://dx.doi.org/10.1136/bmjopen-2022-070823

Ejemplares similares